GALA RENEE D

Average Profitability
17.22%
Insider Buys Quantity
4
Insider Buys Sum
$398,601.50
Insider Sells Quantity
5
Insider Sells Sum
$4.04M

Insider Activity of GALA RENEE D

The largest purchase of all time was on 2018-03-07 and amounted to 9000 shares of Corcept Therapeutics Incorporated for $139,802.

The largest sale of all time was on 2018-08-15 and amounted to 83078 shares of Theravance Biopharma, Inc. for $2.22M.

Biography of GALA RENEE D

No biography is available at this moment.

2023-05-18SaleJazz Pharmaceuticals plc
JAZZ
EVP & Chief Financial Officer
6,000
0.0094%
$131.75$790,474-5.13%
2022-12-21SaleJazz Pharmaceuticals plc
JAZZ
EVP & Chief Financial Officer
2,635
0.0042%
$160.00$421,600-15.58%
2018-08-15SaleTheravance Biopharma, Inc.
TBPH
SVP, Chief Financial Officer
83,078
0.1526%
$26.74$2.22M-8.53%
2018-08-14SaleTheravance Biopharma, Inc.
TBPH
SVP, Chief Financial Officer
4,408
0.0082%
$27.74$122,272-10.69%
2018-05-18SaleTheravance Biopharma, Inc.
TBPH
SVP, Chief Financial Officer
20,000
0.0371%
$24.29$485,754+4.81%
2018-03-07PurchaseCorcept Therapeutics Incorporated
CORT
director
9,000
0.0077%
$15.53$139,802-10.84%
2018-03-06PurchaseCorcept Therapeutics Incorporated
CORT
director
1,000
0.0009%
$15.30$15,300-8.81%
2015-08-17PurchaseTheravance Biopharma, Inc.
TBPH
SVP, Chief Financial Officer
10,000
0.0299%
$12.16$121,600+43.79%
2015-08-13PurchaseTheravance Biopharma, Inc.
TBPH
SVP, Chief Financial Officer
10,000
0.0303%
$12.19$121,900+44.73%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.